Yingdong Zhao

5PUBLICATIONS
23CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 19, 2025
A Phase I Study of Nilotinib in Combination with Paclitaxel in Patients with Advanced Solid Tumors.

Sarah J Shin, Geraldine O'Sullivan Coyne, Shivaani Kummar

|Aug 05, 2024
Insights into gemcitabine resistance in pancreatic cancer: association with metabolic reprogramming and TP53 pathogenicity in patient derived xenografts.

Mariam M Konaté, Julia Krushkal, Ming-Chung Li

|Feb 19, 2024
Association of changes in expression of <i>HDAC</i> and <i>SIRT</i> genes after drug treatment with cancer cell line sensitivity to kinase inhibitors.

Julia Krushkal, Yingdong Zhao, Kyle Roney

|Aug 27, 2021
TPWshiny: an interactive R/Shiny app to explore cell line transcriptional responses to anti-cancer drugs.

Peter Zhang, Alida Palmisano, Ravindra Kumar

|Jun 23, 2021
TPM, FPKM, or Normalized Counts? A Comparative Study of Quantification Measures for the Analysis of RNA-seq Data from the NCI Patient-Derived Models Repository.

Yingdong Zhao, Ming-Chung Li, Mariam M Konaté

Pageof 1

Frequent Collaborators

2 joint publications

Alida Palmisano

2 joint publications

Julia Krushkal

1 joint publications

Ravindra Kumar

1 joint publications

Lisa M McShane